Medical Oncology - Find a Physician or Specialist - Corewell Health

Summary: - The START Center for Cancer Research (START) is a biotechnology contract research organization with multiple locations, including START Midwest in Grand Rapids, Michigan. - Key activities include early-phase clinical trials (Phase 1/1b) for cancer therapies, collaborations with sponsors like AbbVie and MonTa Biosciences, and ongoing patient dosing in studies such as ABBV-438 for multiple myeloma and MBS8 studies in Madrid (Madrid reference appears in milestones but not directly in Grand Rapids). - The Grand Rapids site is one of START’s 11 offices worldwide, contributing to the organization’s 4-country footprint and 221 employees (as of the latest data). - Recent milestones (notable for Midwest/Grand Rapids context) include patient dosing in related START centers and publications by START investigators, underscoring active trial activity across the Midwest network. If you’re specifically researching START Midwest in Grand Rapids, you may want to look for: - Local trial listings or contact details for the Grand Rapids site. - Current Phase 1/1b studies recruiting at START Midwest. - Links to press releases or investor updates mentioning Grand Rapids milestones.

The Cancer & Hematology Centers (CHC) is Michigan’s largest privately owned oncology/hematology practice, founded in 1979 and headquartered in Grand Rapids. CHC provides comprehensive, contemporary cancer care with a compassionate patient focus. It operates 8 offices across Michigan, including locations in Grand Rapids, Muskegon, and Holland, with a notable Grand Rapids presence at 145 Michigan St NE, Suite 3100. Contact options include main numbers: (800) 411-7999 and (616) 975-6149.